No third party may fundamentally publish the work of another without their consent. The BfR is therefore exercising its rights as a scientific institute. This procedure is independent of the scientific assessment. Addendum I has been published for years on the European Food Safety Authority (EFSA) website. All professionally qualified conclusions are therefore publicly accessible. […]Continue Reading ...
A study published today in JAMA Internal Medicine reveals the best assessment tools available to establish the severity of diagnosed delirium in hospitalized patients. Delirium is a common, serious, and often preventable complication among older adult patients. This is an important step in the management of delirium in older adults because the ability to quantify […]Continue Reading ...
Researchers from Universidad Politécnica de Madrid and Hospital Instituto Guttman have developed a new methodology of motor assessment of patients with acquired brain injury that improves the current neurorehabilitation models. Due to the lack of objective assessment tools for patients with acquired brain injury, a team of researchers from Universidad Politécnica de Madrid (UPM) in […]Continue Reading ...
June 29, 2018 Every day we are exposed to low levels of hundreds of different manmade chemicals present for example in our food, consumer products and the air we breathe. Our environment too is exposed to a near-infinite number of chemical mixtures derived from numerous sources. However, current safety assessment practice is primarily based on […]Continue Reading ...
Already in 2013, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined in an early benefit assessment whether ingenol mebutate offers greater benefit than the appropriate comparator therapy (ACT) for patients with actinic keratosis. With the drug manufacturer presenting no suitable study data at that time, the conclusion was “added benefit not […]Continue Reading ...
About one decade after its first benefit assessment of negative pressure wound therapy (NPWT), the German Institute for Quality and Efficiency in Health Care (IQWiG) is reassessing this treatment method. However, then as now, its benefit and harm are unclear. Whereas only few studies with very limited informative value were available in 2006, over 100 […]Continue Reading ...
May 4, 2018 People in chronic pain are some of the most difficult patients to treat. They have complex circumstances that medicine can’t always remedy. Pain can be amplified, by depression and anxiety, genetics and quality of life. Genetics can also play a role in how people experience pain. Physicians are less prone to prescribe […]Continue Reading ...
- New gene therapy cures babies with fatal ‘Bubble Boy’ disease
- No female mice? Scientists may still approve NIH grant
- What needs to be said about mental health in medicine
- Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
- Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
- Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
- Adhesive gel bonds to eye surface, could repair injuries without surgery
- The future of genomics: A podcast featuring Stanford geneticists
- As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
- APOE gene impacts sleep depending on gender and severity of Alzheimer’s
- PCORI’s newly approved awards focus on cancer pain and opioid use disorders
- New tool provides a standard way to measure effects of caring for survivors of TBI
- Smartphone use risks eye examination misdiagnosis
- How drug-resistant bugs grow in CF patients’ lungs
- Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
- Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
- Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
- New estimation method assesses natural variations in sex ratio at birth
- UTA scientist receives $1.17 million grant for cancer research
- Coagulation factor VIIa prevents bleeds in hemophilia animal models